Recurrent oropharyngeal squamous cell carcinomas maintain anti-tumor immunity and multinucleation levels following completion of radiation

OBJECTIVE: Oropharyngeal squamous cell carcinoma (OPSCC) recurrence is almost universally fatal. Development of effective therapeutic options requires an improved understanding of recurrent OPSCC biology. METHODS: We analyzed paired primary-recurrent OPSCC from Veterans treated at the Michael E. DeB...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Patricia, Corredor, Germán, Koyuncu, Can, Nordstrom, Luke A., Tiji, Michelle, Leavitt, Taylor, Lewis, James S., Madabhushi, Anant, Frederick, Mitchell J., Sandulache, Vlad C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479446/
https://www.ncbi.nlm.nih.gov/pubmed/37674722
http://dx.doi.org/10.21203/rs.3.rs-3267009/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479446/
https://www.ncbi.nlm.nih.gov/pubmed/37674722
http://dx.doi.org/10.21203/rs.3.rs-3267009/v1

Ejemplares similares